BioPharm Systems to Host Webinar on Streamlining a Global Life Sciences Company’s Pharmacovigilance Operations
Leading provider of Oracle’s clinical trial, data, and drug safety software will discuss a major pharmaceutical company’s pharmacovigilance globalization initiative that helped standardize and streamline its operations.
San Mateo, California (PRWEB) June 06, 2012
Who: Rodney Lemery, Ph.D., vice president, safety and pharmacovigilance, BioPharm Systems
As the focus on international product safety regulations increases, life sciences organizations must globalize and enhance their safety and pharmacovigilance operations in order to successfully navigate through the challenges they are presented with.
Join BioPharm Systems’ Dr. Rodney Lemery, vice president of safety and pharmacovigilance, for this free one-hour webinar that will discuss a major pharmaceutical company’s pharmacovigilance globalization initiative that helped standardize and streamline its operations.
Specific topics that will be examined include:
– SOP Integration
– Standardization of Local Practices
– Departmental Coordination
– Varying Reporting Requirements
When: Wednesday, July 18, 2012 @:
7:00 a.m. US Pacific time
8:00 a.m. US Mountain time
9:00 a.m. US Central time
10:00 a.m. US Eastern time
15:00 UK time
16:00 Central European time
Webinar Information: To register for this complimentary webinar, go to: https://cc.readytalk.com/r/13y2ji4efivk
BioPharm Systems is an Oracle Accelerate partner and a Gold member in Oracle PartnerNetwork.
About Oracle Accelerate
Oracle Accelerate is Oracle’s approach to provide rapid implementation business software solutions to midsize organizations. Oracle Accelerate solutions include Oracle’s enterprise-class software delivered with business accelerators by expert implementers. Business accelerators are rapid implementation tools, templates and industry- and geography-specific leading practice process flows to help dramatically reduce implementation time, complexity, cost, and risk. To find out more, visit oracle.com/accelerate.
About Oracle PartnerNetwork
Oracle PartnerNetwork (OPN) Specialized is the latest version of Oracle’s partner program that provides partners with tools to better develop, sell and implement Oracle solutions. OPN Specialized offers resources to train and support specialized knowledge of Oracle products and solutions and has evolved to recognize Oracle’s growing product portfolio, partner base and business opportunity. Key to the latest enhancements to OPN is the ability for partners to differentiate through Specializations. Specializations are achieved through competency development, business results, expertise, and proven success. To find out more, visit oracle.com/partners.
About BioPharm Systems
BioPharm Systems is an IT consulting company that focuses on the life sciences industry. We have extensive experience in the implementation, integration, migration, upgrade, and hosting of the following Oracle clinical trial management, drug safety and pharmacovigilance, clinical data warehousing and analytics, clinical data management, and electronic data capture systems: Siebel Clinical, LabPas, Argus Safety Suite (Argus Safety, Argus Safety Japan, Affiliate, Interchange, Reconciliation, Dossier, Insight, and Perceptive), Adverse Event Reporting System (AERS), Empirica Signal, Empirica Topics, Life Sciences Data Hub (LSH), Clinical Development Analytics (CDA), Oracle Clinical, Remote Data Capture (RDC), and Thesaurus Management System (TMS).
Founded in 1995 and headquartered in California, BioPharm Systems has offices in the United States and the United Kingdom. To learn more about the company’s products and services, please call +1 877 654 0033 (U.S.), +44 (0) 1865 910200 (U.K.), or e-mail info(at)biopharm(dot)com.
Oracle and Java are registered trademarks of Oracle and/or its affiliates.
North America Sales Contact:
+1 877 654 0033
Europe/Middle East/Africa Sales Contact:
+44 (0) 1865 910200
+1 617 795 2032
Google Plus: plus.google.com/104105608638786200757
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebpharmacovigilance/drug-safety-system/prweb9473753.htm